[Alnylam Pharmaceuticals](https://www.alnylam.com/about-alnylam)

May 29, 2026 (full proposal submission deadline for RFP ALNY-RFP-TTR-13)

Up to $250,000 per proposal; multiple awards possible; funding amount may differ from amount requested.

Supports independent educational initiatives to advance clinical decision-making in transthyretin-mediated amyloidosis (ATTR-CM).

Open to organizations (not individuals); proposals must address practical clinical gaps in ATTR-CM care.

--- ## Description This grant opportunity, offered by Alnylam Pharmaceuticals, seeks to fund independent, high-impact educational initiatives focused on advancing clinical decision-making in transthyretin-mediated amyloidosis (ATTR-CM). The program is designed to address persistent gaps in screening, diagnosis, monitoring, and management of ATTR, with an emphasis on practical, real-world clinical application and multidisciplinary care. Educational content should be evidence-based, actionable, and tailored to healthcare professionals involved in the management of ATTR-CM, such as cardiologists and clinical pharmacists. The initiative encourages proposals that leverage interactive educational formats, digital platforms, and region-specific channels to maximize reach and relevance. The funding supports activities such as symposia at major cardiology congresses, digital CME platforms, and regional programs, with the ultimate goal of improving patient outcomes through enhanced clinician knowledge and decision-making. --- ## Due Dates - May 29, 2026: Full proposal submission deadline for RFP ALNY-RFP-TTR-13 (Advancing Clinical Decision-Making in ATTR-CM) --- ## Funding Amount - Maximum award: Up to $250,000 USD per proposal - Multiple proposals may be funded (e.g., for different congresses or channels) - The final funded amount may differ from the amount requested; applicants are encouraged to seek additional sources of support --- ## Eligibility - **Eligible applicants:** - Professional associations - Patient advocacy organizations - Healthcare institutions - Medical education companies (must be ACCME-accredited if proposing CME activities) - Other organizations committed to healthcare improvement - **Ineligible applicants:** - Individuals (e.g., individual healthcare providers) - Healthcare provider practice groups or provider-owned clinics - Managed care organizations - Pharmacy benefit managers - **Other requirements:** - Proof of valid, government-issued tax status is required - CME activities must be accredited by the appropriate accrediting bodies (e.g., ACCME) --- ## Application Process - Submit proposals electronically via the [Alnylam Grants Portal](https://alnylam-grants.steeprockinc.com/) or through the [Alnylam Grants and Giving web page](https://www.alnylam.com/about-alnylam/grants-and-giving). - Proposals must include: - Comprehensive gap analysis/needs assessment - Detailed target audience description and recruitment plan - Clearly defined, measurable learning objectives - Overview of unbiased, evidence-based content - Interactive educational design and faculty recruitment plan - Evaluation and outcomes reporting methods - Detailed, line-item budget (grant funds may not be used for attendee HCP meals) - Proof of accreditation (if applicable) - Conflict of interest management and disclosure plans - Dissemination and sustainability strategies - Timeline for development, launch, and reporting - Proposals must be submitted in English and at least 45 days prior to the proposed activity start date. --- ## Additional Information - Notification of funding decisions will be sent via email by June 12, 2026. - Funded activities should aim for a preferred launch by August 2026. - Grant recipients must complete a reconciliation within 90 days of program end, returning any unused funds. - Alnylam may request additional information and reserves the right to fund discrete events within multi-venue proposals. - All activities must comply with relevant laws, codes, and transparency requirements. --- ## External Links - [Alnylam Grants and Giving Program Overview](https://www.alnylam.com/about-alnylam/grants-and-giving#sponsorships) - [Full RFP Document (PDF)](https://www.alnylam.com/sites/default/files/pdfs/ALNY-RFP-TTR-13%20Advancing%20Clinical%20Decision-Making%20in%20ATTR-CM.pdf) - [Alnylam Grants Submission Portal](https://alnylam-grants.steeprockinc.com/) --- ## Contact Information | Purpose | Contact | |--------------------------|------------------------------------------| | General inquiries/RFP | [grants@alnylam.com](mailto:grants@alnylam.com) | | Funder homepage | [Alnylam Pharmaceuticals](https://www.alnylam.com/about-alnylam) | | Submission portal | [Alnylam Grants Portal](https://alnylam-grants.steeprockinc.com/) |

Grants and Giving

Sign in to see full grant listing